Valeritas Inc.

BRIDGEWATER, New Jersey, September 12, 2011 - -- Welsh, Carson, Anderson & Stowe led the financing and assumes a controlling interest in Valeritas -- Financing will support the commercialization of the V-Go™ Disposable Insulin Delivery Device with a primary focus on adult patients with Type 2 diabetes who require insulin Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it has completed a significant Series C round of financing of $150 million.

BRIDGEWATER, New Jersey, July 25, 2011 - Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it received CE Mark approval for its V-Go™ Disposable Insulin Delivery Device as well as ISO 13485: 2003 Quality Management System Certification.